APA

Lin L., Xu J., Wang Y., Ge F., Liu L., Zhao C., Li S., Liu J. & Li Z. (20111202). [Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer]. : Zhonghua zhong liu za zhi [Chinese journal of oncology].

Chicago

Lin Li, Xu Jian-ming, Wang Yan, Ge Fei-jiao, Liu Lie-jun, Zhao Chuan-hua, Li Shan-shan, Liu Jian-zhi and Li Zhi-qiang. 20111202. [Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer]. : Zhonghua zhong liu za zhi [Chinese journal of oncology].

Harvard

Lin L., Xu J., Wang Y., Ge F., Liu L., Zhao C., Li S., Liu J. and Li Z. (20111202). [Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer]. : Zhonghua zhong liu za zhi [Chinese journal of oncology].

MLA

Lin Li, Xu Jian-ming, Wang Yan, Ge Fei-jiao, Liu Lie-jun, Zhao Chuan-hua, Li Shan-shan, Liu Jian-zhi and Li Zhi-qiang. [Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer]. : Zhonghua zhong liu za zhi [Chinese journal of oncology]. 20111202.